How Lab agnostic Genomic Data Ingestion Is Automating the Oncology Clinical Trial Screening Process. The interpretation of genomic test results is challenging for those untrained in this field.
The modern world actively seeks to make the mechanisms and functions of our lives easier. But while attempting to make life easier, we often face challenges along the way.
Modern medicine has changed, so it seems rather odd that our processes in medicine, for the most part, haven't. For our founder David Billiter, this was a problem he wanted to solve.
Simon Arkell was recently interviewed by Dan Sfera for his podcast "Random Musings From The Clinical Trials Guru".
Patients won't participate in a clinical trial if it's too much of a burden, so we have to bring the trials to where the patients live, explained Katie Goodman, RN, BSN, CCRP, Director of Clinical Research, Florida Cancer Specialists & Research Institute.
Our website contains links to websites owned and operated by third parties. If you use these links, you leave our website. These links are provided for your information and convenience only and are not an endorsement by Deep Lens of the content of such linked websites or third parties. Deep Lens has no control over the contents of any linked website and is not responsible for these websites or their content or availability.